FIELD: medicine, microbiology, pharmacy. SUBSTANCE: medicinal preparation comprises botulinic toxin isolated from culture Clostridium botulinum type A, strain = 98, as a liquid substance dissolved mainly in 0.87% 0.04 M solution of sodium chloride, pH 4.9-6.9. Method for preparing medicinal preparation involves preparing botulinic toxin type A from culture Clostridium botulinum, strain = 98, by its culturing at temperature 29-30 C for 3-6 days in nutrient medium. Then dry ammonium sulfate is added slowly to cultural fluid to form precipitate, prepared suspension is centrifuged to isolate precipitate and isolated liquid phase is extracted and subjected for purification. Process of purification of liquid substance is carried out for two stages where at the first step nickel-base metallosorbent is used mainly and at the second step ion-exchange sorbent at pH 6.1-6.9 is used. Sterilization of purified substance is carried out by membrane filtration. Invention provides preparing the preparation no losing activity in liquid form. EFFECT: improved preparing method, valuable medicinal properties of preparation. 3 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR TREATMENT OF MUSCULAR DYSTONIA FROM TOXIN OF CULTURE CLOSTRIDIUM BOTULINUM AND METHOD FOR ITS PREPARING | 2004 |
|
RU2255761C1 |
METHOD FOR PRODUCTION OF NEUROMUSCULAR RELAXANT DRUG FOR TREATMENT OF MUSCLE DYSTONIAS | 2005 |
|
RU2292910C2 |
STRAIN OF HYBRID CELLS OF ANIMALS Mus musculus 3F11 - PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC TO BOTULINUS TOXIN TYPE B | 2014 |
|
RU2566553C1 |
METHOD FOR PREPARING PURIFIED PREPARATION OF BOTULINIC TOXIN TYPE A | 2002 |
|
RU2230325C2 |
STRAIN OF HYBRID ANIMAL CELLS Mus musculus 1G7 - PRODUCER OF MONOCLONAL ANTIBODIES SPECIFIC FOR BOTULINUM TOXIN OF TYPE B | 2014 |
|
RU2571208C1 |
METHOD FOR BOTULINUM TOXIN PRODUCTION | 2014 |
|
RU2627159C2 |
METHOD OF OBTAINING BOTULINUM NEUROTOXIN (VERSIONS) | 2010 |
|
RU2561459C2 |
LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE | 2017 |
|
RU2741497C2 |
COMPLEX, AGENT AND APPLICATION OF TYPE A BOTULINUM TOXIN CLOSTRIDIUM BOTULINUM | 2020 |
|
RU2783511C1 |
RECOMBINANT PLASMID DNA ENCODING SYNTHESIS, METHOD FOR PREPARING AND PREPARATION OF HUMAN RECOMBINANT GAMMA-INTERFERON | 2002 |
|
RU2214832C1 |
Authors
Dates
2003-06-20—Published
2002-10-29—Filed